Sherbrooke Park Advisers’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,379
Closed -$133K 692
2025
Q1
$133K Buy
+10,379
New +$167K 0.06% 480
2024
Q4
Sell
-19,737
Closed -$451K 1038
2024
Q3
$451K Sell
19,737
-8,440
-30% -$191K 0.1% 351
2024
Q2
$647K Buy
28,177
+21,750
+338% +$670K 0.11% 303
2024
Q1
$255K Buy
6,427
+947
+17% +$37.5K 0.05% 632
2023
Q4
$217K Buy
+5,480
New +$229K 0.1% 315

Other funds holding NRC

Sherbrooke Park Advisers's NRC Position: Q2 2025 in Review

Sherbrooke Park Advisers sold out of NRC Health Common Stock (NRC) in Q2 2025, closing a stake of 10,379 shares — an estimated $133K sold.

Sherbrooke Park Advisers first reported a position in NRC in Q4 2023 and held it in 5 quarters. The position peaked at $647K in Q2 2024. 126 funds tracked by Wall St. Rank hold NRC as of Q2 2025.

  • Sherbrooke Park Advisers reported no remaining NRC Health Common Stock position as of Q2 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 10,379 NRC Health Common Stock shares in Q2 2025, an estimated $133K.
  • Sherbrooke Park Advisers first reported a position in NRC Health Common Stock in Q4 2023 and held it in 5 quarters.
  • Sherbrooke Park Advisers's NRC Health Common Stock position peaked at $647K in Q2 2024.
  • 126 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.